The Global Macrolide Drugs market is expected to be around US$ 8.70 Billion by 2028 at a CAGR of 3.5% in the given forecast period.
The growing prevalence and recurrence of bacterial infections is expected to be the major factor driving the growth of the macrolide drug market over the forecast period. Growing elderly population is also one of the factors expected to surge the growth of the macrolide drug market. The side effects of macrolide drugs such as gastro intestinal disturbances, e.g., nausea, diarrhea, and vomiting, is projected to restrain the growth of the macrolide drug market over the forecast period.
The macrolide drugs are a group of antibiotics created by varied strains of Streptomyces (spore forming microorganism that grow slowly in soil or water as a branching thin plant structure like that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by obstruction the 50S ribosomal subunit. They form a broad spectrum antibiotics.
The global Macrolide Drugs market is segregated on the basis of Application as Hospitals, Clinics, Hospitals hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Type the global Macrolide Drugs market is segmented in 14-Membered Ring Agents, 15-Membered Ring Agents, 16-Membered Ring Agents, and Ketolides.
The global Macrolide Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Macrolide Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abbott Laboratories, Akorn, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT, and others are among the major players in the global Macrolide Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Macrolide Drugs Market has been segmented as below:
Macrolide Drugs Market, By Application
Macrolide Drugs Market, By Type
Macrolide Drugs Market, By Region
Macrolide Drugs Market, By Company
The report covers:
Report Scope:
The global Macrolide Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Macrolide Drugs market share. Major industry players with significant revenue share include Abbott Laboratories, Akorn, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Medical non-woven disposable market
Netilmicin (CAS 56391-56-1) Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Macrolide Drugs Market, By Application
5.1 Introduction
5.2 Hospitals
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Clinics
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Hospitals hospital Pharmacies
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Retail Pharmacies
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Online Pharmacies
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6. Macrolide Drugs Market, By Type
6.1 Introduction
6.2 14-Membered Ring Agents
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 15-Membered Ring Agents
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 16-Membered Ring Agents
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Ketolides
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Macrolide Drugs Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Macrolide Drugs, By Application
7.2.2 North America Macrolide Drugs, By Type
7.3 Europe
7.3.1 Europe Macrolide Drugs, By Application
7.3.2 Europe Macrolide Drugs, By Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Macrolide Drugs, By Application
7.4.2 Asia-Pacific Macrolide Drugs, By Type
7.5 Rest of the World
7.5.1 Rest of the World Macrolide Drugs, By Application
7.5.2 Rest of the World Macrolide Drugs, By Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Akorn
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Macrolide Pharmaceuticals
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Mylan
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Pfizer
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Sanofi
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Merck & Co.
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Sandoz International
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Teva Pharmaceutical Industries
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 WOCKHARDT
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Macrolide Drugs Market has been segmented as below:
Macrolide Drugs Market, By Application
Macrolide Drugs Market, By Type
Macrolide Drugs Market, By Region
Macrolide Drugs Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
